Literature DB >> 21293898

Comparison of LEP and QST and their contribution to standard sensory diagnostic assessment of spinal lesions: a pilot study.

Christian Geber1, Ulf Baumgärtner, Marcel Fechir, Thomas Vogt, Frank Birklein, Rolf-Detlef Treede.   

Abstract

This study evaluates the additional use of laser-evoked potentials (LEP) and quantitative sensory testing (QST) in the sensory assessment of spinal lesions. Four consecutive patients with spinal lesions verified by MRI and clinical evidence for mild spinothalamic tract involvement were included. The electrophysiological workup [somatosensory evoked potentials (SEP) and LEP] was compared to QST. Electrophysiology and QST were reassessed after about 6 months. LEP detected impaired spinothalamic tract function in 7/8 examinations. QST pointed to spinothalamic tract lesions by loss of thermal function (3/8); most frequent positive sensory signs (3/8) were paradoxical heat sensations. LEP and QST results were concordant in 6/8 examinations. SEPs were abnormal in 2/8 examinations. Congruent results between SEP and both LEP and QST were obtained in 3/8 examinations. LEP detected more deficits than any single QST parameter or their combination but additional QST allows the detection of positive sensory signs. The diagnostic gain of SEP was limited.

Entities:  

Mesh:

Year:  2011        PMID: 21293898     DOI: 10.1007/s10072-011-0476-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  21 in total

1.  Somatosensory evoked potentials. The International Federation of Clinical Neurophysiology.

Authors:  F Mauguière; T Allison; C Babiloni; H Buchner; A A Eisen; D S Goodin; S J Jones; R Kakigi; S Matsuoka; M Nuwer; P M Rossini; H Shibasaki
Journal:  Electroencephalogr Clin Neurophysiol Suppl       Date:  1999

2.  Afferent pathways of sympathetic skin response in spinal cord: a clinical and electrophysiological study.

Authors:  K P Nair; A B Taly; S Rao; T Murali
Journal:  J Neurol Sci       Date:  2001-06-15       Impact factor: 3.181

Review 3.  Clinical usefulness of laser-evoked potentials.

Authors:  Rolf-Detlef Treede; Jürgen Lorenz; Ulf Baumgärtner
Journal:  Neurophysiol Clin       Date:  2003-12       Impact factor: 3.734

4.  Clinical characteristics, course and prognosis of spinal multiple sclerosis.

Authors:  V Nociti; A Cianfoni; M Mirabella; M Caggiula; G Frisullo; A K Patanella; C Sancricca; F Angelucci; P A Tonali; A P Batocchi
Journal:  Spinal Cord       Date:  2005-12       Impact factor: 2.772

5.  Non-painful sensory phenomena after spinal cord injury.

Authors:  P J Siddall; J McClelland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

6.  Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease.

Authors:  Philip M Lang; Gabriel M Schober; Roman Rolke; Susanne Wagner; Robert Hilge; Martin Offenbächer; Rolf-Detlef Treede; Ulrich Hoffmann; Dominik Irnich
Journal:  Pain       Date:  2006-05-22       Impact factor: 6.961

7.  Cerebral potentials evoked by painful, laser stimuli in patients with syringomyelia.

Authors:  R D Treede; J Lankers; A Frieling; W H Zangemeister; K Kunze; B Bromm
Journal:  Brain       Date:  1991-08       Impact factor: 13.501

8.  EFNS guidelines on neuropathic pain assessment.

Authors:  G Cruccu; P Anand; N Attal; L Garcia-Larrea; M Haanpää; E Jørum; J Serra; T S Jensen
Journal:  Eur J Neurol       Date:  2004-03       Impact factor: 6.089

Review 9.  PET studies in dementia.

Authors:  Karl Herholz
Journal:  Ann Nucl Med       Date:  2003-04       Impact factor: 2.668

Review 10.  Demyelinating disorders: update on transverse myelitis.

Authors:  Chitra Krishnan; Adam I Kaplin; Carlos A Pardo; Douglas A Kerr; Sanjay C Keswani
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 6.030

View more
  9 in total

Review 1.  Quantitative sensory testing of neuropathic pain patients: potential mechanistic and therapeutic implications.

Authors:  Doreen B Pfau; Christian Geber; Frank Birklein; Rolf-Detlef Treede
Journal:  Curr Pain Headache Rep       Date:  2012-06

2.  Pain: Quantitative sensory testing--a tool for daily practice?

Authors:  Frank Birklein; Claudia Sommer
Journal:  Nat Rev Neurol       Date:  2013-08-06       Impact factor: 42.937

Review 3.  Neuropathic pain: is quantitative sensory testing helpful?

Authors:  Elena K Krumova; Christian Geber; Andrea Westermann; Christoph Maier
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 4.  [Pain in patients with paraplegia].

Authors:  G Landmann; E-C Chang; W Dumat; A Lutz; R Müller; A Scheel-Sailer; K Schwerzmann; N Sigajew; A Ljutow
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

5.  Usefulness of laser-evoked potentials and quantitative sensory testing in the diagnosis of neuropathic spinal cord injury pain: a multiple case study.

Authors:  G Landmann; M F Berger; L Stockinger; E Opsommer
Journal:  Spinal Cord       Date:  2017-01-24       Impact factor: 2.772

6.  Complex Regional Pain Syndrome or Limb Pain: A Plea for a Critical Approach.

Authors:  Astrid Juhl Terkelsen; Frank Birklein
Journal:  J Pain Res       Date:  2022-07-08       Impact factor: 2.832

Review 7.  [Neuropathic pain. How to open the blackbox].

Authors:  C Maier; R Baron; C Sommer
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

8.  Reliability and Validity of the Boston Bedside Quantitative Sensory Testing Battery for Neuropathic Pain.

Authors:  Alexandra E Koulouris; Robert R Edwards; Kathleen Dorado; Kristin L Schreiber; Asimina Lazaridou; Sharika Rajan; Jeffrey White; Jenniffer Garcia; Christopher Gibbons; Roy Freeman
Journal:  Pain Med       Date:  2020-10-01       Impact factor: 3.750

9.  NerveCheck: An inexpensive quantitative sensory testing device for patients with diabetic neuropathy.

Authors:  G Ponirakis; M N Odriozola; S Odriozola; I N Petropoulos; S Azmi; H Fadavi; U Alam; O Asghar; A Marshall; A Miro; A Kheyami; A Al-Ahmar; M B Odriozola; A Odriozola; R A Malik
Journal:  Diabetes Res Clin Pract       Date:  2016-01-14       Impact factor: 5.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.